Generics makers appeal pay-for-delay ban to Ninth Circuit

A group of generics manufacturers yesterday, December 2 asked the US Court of Appeals for the Ninth Circuit to reverse California’s ban on pay-for-delay deals.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

California outlaws pay-for-delay deals

9 October 2019 California has become the first US state to ban pay-for-delay deals in the pharmaceutical industry.

Americas

California mulls state generics brand

13 January 2020 California’s governor wants the state to establish its own generics brand in a bid to bring down the cost of prescription drugs.

Americas

California pay-for-delay ban upheld during appeal, rules Ninth Circuit

25 February 2020 The US Court of Appeals for the Ninth Circuit has blocked generics makers’ request to halt California’s ban on pay-for-delay deals while they challenge the legislation.

More on this story

Americas

California outlaws pay-for-delay deals

9 October 2019 California has become the first US state to ban pay-for-delay deals in the pharmaceutical industry.

Americas

California mulls state generics brand

13 January 2020 California’s governor wants the state to establish its own generics brand in a bid to bring down the cost of prescription drugs.

Americas

California pay-for-delay ban upheld during appeal, rules Ninth Circuit

25 February 2020 The US Court of Appeals for the Ninth Circuit has blocked generics makers’ request to halt California’s ban on pay-for-delay deals while they challenge the legislation.

More on this story

Americas

California outlaws pay-for-delay deals

9 October 2019 California has become the first US state to ban pay-for-delay deals in the pharmaceutical industry.

Americas

California mulls state generics brand

13 January 2020 California’s governor wants the state to establish its own generics brand in a bid to bring down the cost of prescription drugs.

Americas

California pay-for-delay ban upheld during appeal, rules Ninth Circuit

25 February 2020 The US Court of Appeals for the Ninth Circuit has blocked generics makers’ request to halt California’s ban on pay-for-delay deals while they challenge the legislation.

More features

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent

Generics makers appeal pay-for-delay ban to Ninth Circuit

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features